COVID-19 vaccination: invitations being sent to risk groups From 27 August 2024 on, the first people will receive an invitation for COVID-19 vaccination. RIVM will send the invitations to people aged 60 years and older.
New COVID-19 vaccination round for risk groups this autumn The new COVID-19 vaccination round will start on 16 September 2024. For people who are at higher risk, the COVID-19 vaccination offers more effective protection against hospital admission or death due to COVID-19.
New research portal for people with post-COVID Starting today, people with post-COVID can sign up to take part in scientific research. They can register through the national portal at postcovidonderzoek.nl, which is part of the Post-COVID Network Netherlands.
Well-being should be considered from the start when formulating policy during pandemic, health emergency or other crisis Monitoring well-being from the outset and throughout the duration of a pandemic, health emergency or other crisis provides helpful input in making policy choices.
Study on the effectiveness of COVID-19 measures in the Netherlands The measures implemented in the Netherlands during the COVID-19 crisis were effective against the spread of the SARS-CoV-2 virus. This is the outcome of a study conducted by RIVM.
Air pollution increases risk of infection and severity of illness from COVID-19 People who live in areas with poor air quality are more likely to become infected with SARS-CoV-2. Moreover, the symptoms of COVID-19 are more severe, leading to more hospitalisations and deaths. This is the outcome of a study conducted by RIVM, Utrecht University, Wageningen University & Research and the Netherlands Municipal Public Health Services and Medical Assistance in Accidents and Disasters.
RIVM European Reference Lab for vector-borne infections The European Commission (EC) has designated RIVM as the current European Reference Lab (EURL) for vector-borne viral pathogens.
Menno de Jong appointed director of RIVM Centre for Infectious Disease Control Starting 1 May 2024, Professor Menno de Jong will take on the role of director of RIVM’s Centre for Infectious Disease Control (CIb) . He succeeds Jaap van Dissel, who is retiring in April 2024.
More than 2.7 million COVID-19 vaccinations administered in the 2023 autumn round In the 2023 autumn round, more than 2,731,000 people in the Netherlands received a COVID-19 vaccination. Vaccination coverage for people over 60 is currently 50.5%. Vaccination coverage varies by age group and region. COVID-19 vaccination was available until 22 December 2023.
Booster vaccinations reduced risk of death from COVID-19 in 2022 Booster vaccinations reduced the risk of dying from COVID-19 in 2022. The risk of death from other causes was also lower for people who had a booster jab than for people without a booster jab. These findings are from research by RIVM.